Pain in Parkinson disease

Neurology

Volumn 62, Issue 12, 2004, Pages 2156-2157

  Buzas, Beata ^a,b   Max, Mitchell B ^a  

^a NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CATECHOL METHYLTRANSFERASE; DESIPRAMINE; LEVODOPA; NORADRENALIN UPTAKE INHIBITOR; VENLAFAXINE;

BASAL GANGLION; CLINICAL TRIAL; DEPRESSION; DOPAMINERGIC SYSTEM; EDITORIAL; EVOKED RESPONSE; GENETIC POLYMORPHISM; HUMAN; LOCUS CERULEUS; MOTOR ACTIVITY; MOTOR DYSFUNCTION; NERVE CELL DEGENERATION; NERVE CELL LESION; NOCICEPTION; PAIN; PAIN THRESHOLD; PARKINSON DISEASE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SENSORY DYSFUNCTION; STROKE; THERMAL ANALYSIS; THERMAL STIMULATION;

EID: 2942718838     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.WNL.0000130384.56476.75     Document Type: Editorial

References (13)

1. Djaldetti R, Shifrin A, Rogowski Z, Sprecher E, Melamed E, Yarnitsky D. Quantitative measurement of pain sensation in patients with Parkinson's disease. Neurology 2004;62:2171-2175.
2. Boivie J. Central pain and the role of quantitative sensory testing (QST) in research and diagnosis. Eur J Pain 2003;7:339-343.
3. Yarnitsky D, Sprecher E, Zaslansky R, Hemli JA. Heat pain thresholds: normative data and repeatability. Pain 1995;60:329-332.
4. Zubieta JK, Heitzeg MM, Smith YR, et al. COMT val158met genotype affects mu-opioid neurotransmitter responses to a pain stressor. Science 2003;299:1240-1243.
5. Jellinger KA. Pathology of Parkinson's disease. Changes other than the nigrostriatal pathway. Mol Chem Neuropathol 1991;14:153-197.
6. Jellinger KA. Post mortem studies in Parkinson's disease - is it possible to detect brain areas for specific symptoms? J Neural Transm Suppl 1999;56:1-29.
7. Zarow C, Lyness SA, Mortimer JA, Chui HC. Neuronal loss is greater in the locus coeruleus than nucleus basalis and substantia nigra in Alzheimer and Parkinson diseases. Arch Neurol 2003;60:337-341.
8. Burnett A, Gebhart GF. Characterization of descending modulation of nociception from the A5 cell group. Brain Res 1991;546:271-281.
9. Nuseir K, Proudfit HK. Bidirectional modulation of nociception by GABA neurons in the dorsolateral pontine tegmentum that tonically inhibit spinally projecting noradrenergic A7 neurons. Neuroscience 2000;96:773-783.
10. Meng XW, Budra B, Skinner K, Ohara PT, Fields HL. Noradrenergic input to nociceptive modulatory neurons in the rat rostral ventromedial medulla. J Comp Neurol 1997;377:381-391.
11. Tanaka M, Matsumoto Y, Murakami T, Hisa Y, Ibata Y. The origins of catecholaminergic innervation in the rostral ventromedial medulla oblongata of the rat. Neurosci Lett 1996;207:53-56.
12. Fields HL, Basbaum AI. Brainstem control of spinal pain-transmission neurons. Annu Rev Physiol 1978;40:217-248.
13. Edelman GM. Neural Darwinism: The Theory of Neuronal Group Selection. New York: Basic Books, 1988.